Heutink, W.P. (2018) Follow up of Advanced Glycation End products in Children and Adolescents with Type I Diabetes Mellitus : FACADE. thesis, Medicine.
Full text available on request.Abstract
Background: Advanced glycation endproducts (AGEs) have a major contribution in the development of micro- and macrovascular disease in children with type 1 diabetes mellitus (T1DM). AGEs can be measured non-invasively with skin autofluorescence (sAF). Predicting the risk on developing diabetic complications in children with T1DM is very important. The primary aim was to monitor the sAF value progression and to evaluate the predictive value of sAF level on the development of micro- and macrovascular disease in children with T1DM. Methods: In children with T1DM, the first sAF measurement was performed between September 2013 and Oktober 2014. The follow-up sAF measurement was performed between March 2016 and May 2018. Anthropometric and laboratory data were extracted from medical charts. sAF level progression was evaluated using a paired t-test, the predictive value of sAF level on the development of complications was studied using student’s t-tests and correlations between sAF values and HbA1c and other related variables were studied using Pearson’s correlation coefficient. Multivariable linear regression analysis was used to evaluate the effect of different study parameters on sAF values. Results: 81 children were included with a mean age of 9.8 ± 3.0, a mean disease duration of 34.5 ± 33.5 months and a mean follow-up period of 46.8 ± 7.2 months. Baseline sAF values increased significantly from 1.24 ± 0.26 AU at baseline to 1.38 ± 0.30 AU at follow-up (p < 0.01). Patients who developed retinopathy (n=3) had higher sAF values than children who did not develop retinopathy (n=50) both at baseline (1.23 ± 0.25 vs. 1.53 ± 0.61) and at follow-up (1.36 ± 0.32 vs. 1.67 ± 0.15). sAF values positively correlated with average HbA1c the year prior to the measurement (r=0.50), average HbA1c over the entire follow-up period (r=0.57), age (r=0.36), disease duration (r=0.32) and serum triglycerides (r = 0.39). Conclusion: sAF measurement reflects long-term glycaemic control, considering a stronger correlation with the HbA1c over the entire follow-up period. Therefore the predictive value of sAF measurement on the development of micro- and macrovascular complications in children with T1DM is promising. However, longitudinal follow-up studies, measuring sAF values and monitoring diabetic complications should be performed.
| Item Type: | Thesis (Thesis) |
|---|---|
| Supervisor name: | Faculty supervisor: and Thio, Dr. B.J. pediatrician and Department of Pediatrics, Medisch Spectrum Twente |
| Supervisor name: | Vorst, Dr. M.M.J. van der pediatrician-clinical pharmacologi and Lentferink, Drs. Y.E. PHD-student and Department of Pediatrics, St. Antonius Hospital |
| Faculty: | Medical Sciences |
| Date Deposited: | 25 Jun 2020 10:41 |
| Last Modified: | 25 Jun 2020 10:41 |
| URI: | https://umcg.studenttheses.ub.rug.nl/id/eprint/241 |
Actions (login required)
 |
View Item |